Wall Street analyst estimates for BNB Plus Corp. (BNBX): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-08-06 | |||
| 2026-05-15 | $-0.68 | ||
| 2026-02-12 | $-2.08 | ||
| 2025-12-22 | $-3.17 | $-22.50 | +85.9% |
| 2025-08-14 | $34.00 | $-37.50 | +190.7% |
| 2025-05-15 | $-2.30 | $-0.45 | -411.7% |
| 2025-02-13 | $-4.20 | $-2.44 | -72.3% |
| 2024-09-30 | $-239.69 | $-255.00 | +6.0% |
Valuation Ratios
| Price / Book | 0.13 |
| EV / EBITDA | -0.04 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $9.0M | $18.2M | $13.4M | $3.4M | $2.1M |
| Cost of Revenue | $4.5M | $13.1M | $7.8M | $2.4M | $1.3M |
| Gross Profit | $4.5M | $5.1M | $5.5M | $1.0M | $838907 |
| Research & Development | $4.2M | $3.9M | $3.7M | $3.6M | $6.0M |
| Selling, General & Admin | $12.8M | $15.1M | $12.8M | $11.4M | $10.9M |
| Operating Expenses | $17.8M | $19.0M | $16.5M | $15.0M | $16.9M |
| Operating Income | -$13.3M | -$14.0M | -$11.0M | -$14.0M | -$16.0M |
| EBITDA | -$11.7M | -$7.0M | -$8.7M | -$6.4M | -$15.3M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -$14.3M | -$8.3M | -$10.0M | -$7.1M | -$15.6M |
| Income Tax | 0 | 0 | 0 | 0 | -$684115 |
| Net Income | -$14.3M | -$8.3M | -$9.9M | -$7.0M | -$15.2M |
| EPS | $-28630.14 | $-9741.86 | $-570.37 | $-68.25 | $-134.23 |
| EPS (Diluted) | $-28630.14 | $-9741.86 | $-570.37 | $-68.25 | $-134.23 |
| Shares Outstanding (Diluted) | $499 | $860 | $17433 | $105760 | $517671 |
Price
| Price | $0.16 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Related companies: BGMS · BNGO · CANF · ISPC · KZIA · NAOV · NDRA
Explore sector: Healthcare · Biotechnology
More sections of BNBX: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks